7th Annual Updates From ASH 2021
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case-Based Clinical Trial Considerations: Follicular Lymphoma
FEATURING
Kirk Cahill
- 14 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Review Case-Based Clinical Trial Considerations: ALL/AML
FEATURING
Caner Saygin
- 16 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Evolving Standards of Care in Lymphoma
FEATURING
Justin Kline
- 6 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
ASH Review: Updates in Nonmalignant Hematology
FEATURING
Kenneth Cohen
- 18 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Myeloma Highlights of ASH 2021
FEATURING
Joseph Mikhael
- 169 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Practice-Changing and Promising New Treatments in Myeloma
FEATURING
Ben Derman
- 357 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Advances in Cellular Therapy and Transplantation
FEATURING
Mariam Nawas
- 16 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH New Strategies in Myeloid Malignancies: AML Treatment
FEATURING
Adam Duvall
- 13 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
ASH Review on Immunotherapies in Leukemia
FEATURING
Hongtao Liu
- 59 views
- March 11, 2022
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH 2021 Faces of Cellular Therapy Nursing: Inpatient Phase
FEATURING
Stephanie Knesek
- 161 views
- March 9, 2022
- 2
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH 2021 Nursing Clinical Trials: It’s Not Trial By Fire
FEATURING
Andrea Fadel
- 79 views
- March 9, 2022
- 1